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ABSTRACT 
The Centers for Disease Control and Prevention (CDC) (2017a) estimates that one-quarter of 
sexually active people are between 15 and 24 years old, but account for half of 20 million 
sexually transmitted diseases (STD) reported annually in the United States. Chlamydia 
trachomatis (CT) and Neisseria gonorrhea (NG) are the most common reportable STDs (CDC, 
2018). The purpose of this project was to increase CT/NG screening rates among sexually 
active, nonpregnant women 15 to 24 years old within the primary care setting through colleague 
education, routine sexual history taking, and indicated testing. A 30-minute colleague in-service 
was provided to educate clinical colleagues on the significance of the problem and best practice 
intervention. During preventive office visit intake with the medical assistant (MA) over a 10-week 
intervention period, women 15 to 24 years old were asked about sexual activity. If a woman 
indicated she was sexually active, CT/NG testing via urine sample were offered. Ten-week pre-
intervention and 10-week post-intervention data including demographics, number screened for 
sexual activity, number eligible for testing based on sexual activity, number tested for CT/NG, 
and number of positive results were collected via manual chart audit. Data between groups 
were analyzed using descriptive statistics and chi-square analyses. There were non-significant 
increases in number screened for sexual activity (61% vs. 79%) (𝝌2(1, N=32)=1.117, p>.05), 
number eligible for testing (45% vs. 64%) (𝝌2(1, n=22)=0.733, p>.05), and number tested for 
CT/NG (80% vs. 100%) (𝝌2(1, n=12)=1.527, p>.05). There was no significant difference 
between pre-intervention and post-intervention positive CT (20% vs. 14%) (𝝌2(1, n=12)=1.527, 
p>.05) or NG (20% vs. 0%) (𝝌2(1, n=12)=1.527, p>.05) results. A longer timeframe or larger 
sample sizes would further explore significance of the intervention. Based on current clinical 
guidelines provided by CDC (2014c) and USPSTF (2014), women 15 to 24 years old should be 
offered CT/NG screening annually.
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CHAPTER 1 
INTRODUCTION 
Background 
The Centers for Disease Control and Prevention (CDC) (2017a) estimates that one-
quarter of sexually active people are between ages 15 and 24 years old, but account for half of 
20 million sexually transmitted diseases (STD), or sexually transmitted infections (STI), reported 
annually in the United States. STDs are infections that are passed through vaginal, anal, and/or 
oral sex (Planned Parenthood, 2019). STDs are very common, but many people do not 
experience symptoms and therefore are often unaware they are infected. Females 15 to 24 
years old have the highest rate of Chlamydia trachomatis infections, representing 62.6% of all 
reported cases in 2017 (CDC, 2017b).  Males 20 to 24 years old have the highest rate of 
Neisseria gonorrhea infections (CDC, 2017b). According to the CDC, incidence of chlamydia 
and gonorrhea are increasing among both males and females 15 to 24 years old (2017b). 
Certain behavioral risk factors increase the risk of STD acquisition such as multiple sex 
partners or sex partner with multiple sex partners, sex with sex workers, no or inconsistent 
condom use, new sex partner in the past 60 days, and sex with sex partners recently treated for 
STDs, among others (Ghanem & Tuddenham, 2018). Particular vulnerable groups of interest 
include young men and women as noted above, men who have sex with men, people with 
history of STD(s), pregnant women, and people using illicit drugs, among others (Ghanem & 
Tuddenhan, 2018).  
STDs like chlamydia and gonorrhea are a cause of public health concern. People 
infected with chlamydia and gonorrhea often do not have symptoms or have minimal symptoms 
(Ghanem & Tuddenham, 2018). These infections can produce short-term and long-term ailment. 
When symptomatic, chlamydia and gonorrhea may produce urogenital symptoms (Ghanem & 
Tuddenham, 2018). In women, this may present as burning with urination, vaginal discharge or 
INCREASING CT AND NG SCREENING  2 
 
odor, or pelvic pain (CDC, 2014a; CDC, 2014b). Men may experience burning with urination, 
penile discharge, or painful ejaculation. In rare cases, chlamydia can cause reactive arthritis 
(USPSTF, 2014) and gonorrhea can spread to the blood and joints and become life threatening 
(CDC, 2014b). Chlamydia and gonorrhea increase both sex’s risk of contracting Human 
Immunodeficiency Virus (HIV) and Human Papilloma Virus (HPV), the virus that causes cervical 
cancer as well as many anal and oropharyngeal cancers (CDC, 2014a; CDC, 2014b; Ghanem & 
Tuddenham, 2018). While less likely among men, untreated infections can lead to reproductive 
sequela. Females may experience pelvic inflammatory disease (PID), chronic pelvic pain, 
difficulty becoming pregnant, and pregnancy complications such as miscarriage, ectopic 
pregnancy, or preterm labor (CDC, 2014a; CDC, 2014b; Ghanem & Tuddenham, 2018). Men 
may become sterile from chronic, untreated gonorrhea infection (CDC, 2014b). Despite 
increasing incidence of chlamydia and gonorrhea infections, screening rates and subsequent 
eradication are suboptimal (Ghanem & Tuddenham, 2018). 
Data from the Literature Supporting Need for the Project 
Nationally, chlamydia and gonorrhea infections are on the rise (CDC, 2018). Young 
women less than 25 years old account for the highest rates of chlamydia and gonorrhea 
infections (CDC, 2017b). According to the Indiana State Department of Health (ISDH) (2017a), 
there were 34,278 reported cases of chlamydia in Indiana in 2017. Of these 34,278 cases, 
20,221 (59%) occurred among men and women 24 years old and younger (ISDH, 2017a). 
Specifically, Elkhart county reported 1,045 cases (ISDH, 2017a). In the same year, there were 
11,835 reported cases of gonorrhea in Indiana (ISDH, 2017b). Of these 11,835 cases, 5,752 
(49%) occurred among men and women 24 years old and younger. Elkhart County reported a 
total of 322 cases (ISDH, 2017b). Given the often asymptomatic presentation of chlamydia and 
gonorrhea, local incidence may be higher than reported. 
 Improved screening of chlamydia and gonorrhea is needed to reduce the burden of 
such infections. The National Committee for Quality Assurance (NCQA) Healthcare 
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Effectiveness Data and Information Set (HEDIS) measures chlamydia screening rates reported 
from several managed care entities. In 2017, 48.9% of commercial health maintenance 
organization (HMO), 46.9% of commercial preferred provider organization (PPO), and 57.6% of 
Medicaid HMO members between 16 to 24 years old were screened for chlamydia (NCQA, 
2019). An analysis of 3,953 adolescents and young adults revealed that 11.5% of respondents 
reported undergoing STD screening in the last year (Cuffe, Newton-Levinson, Gift, McFarlane, 
& Leichliter, 2016).  
Patient barriers noted in the Cuffe et al. (2016) survey include confidentiality concerns or 
feeling they are not at risk. Provider barriers include a lack of knowledge of current guidelines or 
understanding of state laws regarding parental consent (Kettinger, 2013). Both patients and 
providers may have concerns regarding cost-effectiveness. According to a multi-practice 
retrospective chart review, decreases in STD screening appear to be an unintended 
consequence of the release of the 2012 cervical cancer screening guidelines, which now 
recommends Papanicolaou tests every three to five years instead of yearly (Bogler et al., 2015). 
Talking about sex is often taboo, so this should also be considered a barrier among both 
parties. 
Strong clinical guidelines call for increased STD screening among the target population. 
The United States Preventive Services Task Force (USPSTF) (2014) and CDC (2014c) 
recommend screening sexually active women less than 25 years old for chlamydia and 
gonorrhea annually. Additionally, a goal of Healthy People 2020 is to increase the proportion of 
sexually active women 24 years old and younger enrolled in commercial and Medicaid plans 
who are screened for chlamydia (United States Department of Health and Human Services 
[HHS], Healthy People 2020, 2019). 
Data from the Clinical Agency Supporting Need for the Project 
Providers at the project clinical site personally attested that STD screening of the target 
population occurs less often than it should. As a team of providers and Certified Medical 
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Assistants (CMA), inconsistency in obtaining necessary sexual histories as well as neglect of 
the provider to routinely recommend screening was noted. The electronic medical record (EMR) 
provides a mean to remind providers and colleagues to screen this population, yet it is often 
overlooked. 
Purpose of the Evidence-Based Practice Project 
The purpose of this evidence-based practice (EBP) project was to improve screening for 
Chlamydia Trachomatis and Neisseria Gonorrhea infections among sexually active, 
nonpregnant females 15 to 24 years old within the primary care setting. This project sought to 
determine effective interventions to improve screening rates to promote early detection and 
eradication of such diseases. This project aimed to increase screening for sexual activity and 
testing for chlamydia and gonorrhea among women at risk. Additionally, this project aimed to 
explore detection rates related to changes in screening interventions.  
PICOT Question 
 Specifically, this project addressed the following PICOT question: Among sexually 
active, nonpregnant women 15 to 24 years old (P), how does colleague education, routine 
sexual history taking, and subsequent collection of urine specimen for sexually active women (I) 
compared to no standard practice (C) improve chlamydia and gonorrhea screening uptake (O) 
over a 10-week period (T)? 
Significance of the EBP Project 
 Chlamydia and gonorrhea are the most common STDs (CDC, 2018). In 2017, two-thirds 
of 1,708,569 chlamydia infections reported nationally were among the 15 to 24 year old age 
group (CDC, 2018). The second most common reportable STD, gonorrhea, accounted for 
558,608 cases in 2017 (CDC, 2018). Both rates continue to climb and many more people may 
be unknowingly infected. 
 Untreated chlamydia and gonorrhea infections can lead to multiple health complications 
which can be costly and generate life-long devastation. Complications cited include urogenital 
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manifestations, reactive arthritis (chlamydia), disseminated gonococcal infection, pelvic 
inflammatory disease, increased acquisition of HIV and HPV, and infertility (USPSTF, 2014). 
The CDC estimates that 24,000 women become infertile each year due to chlamydia or 
gonorrhea reproductive sequela (CDC, 2013). The National Commission on Prevention 
Priorities asserts that if 90% of sexually active young women were screened for chlamydia 
infection each year, 30,000 cases of pelvic inflammatory disease would be prevented (2007). It 
is estimated that chlamydia and gonorrhea, collectively, are associated with annual costs of 
approximately 678.8 million dollars in the United States alone (USPSTF, 2014).  
 This doctoral EBP project is valuable to reduce burden of STDs, specifically chlamydia 
and gonorrhea. This project served to increase patient and provider awareness of such 
infections, ask the hard questions related to sexual history, and reduce risk through targeted 
STD screening and prompt intervention. This multifaceted project over time could improve the 
clinical problem related to suboptimal chlamydia and gonorrhea screening among young women 
24 years old and younger. Alleviating the identified clinical problem will help reduce health care 
costs and reproductive sequela. 
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CHAPTER 2 
EBP MODEL AND REVIEW OF LITERATURE 
Evidence-based Practice Model 
Overview of EBP Model 
 The ACE Star Model was utilized for this EBP project. The ACE Star Model was created 
by Dr. Kathleen Stevens as a way to systematically assimilate primary search findings into EBP 
(Stevens, 2012). The step wise approach outlines five stages of transformation: discovery 
research, evidence summary, translation to guidelines, practice integration, and 
process/outcome evaluation. This model depicts the cycle of knowledge necessary to apply 
evidence into practice that will ultimately impact patient outcomes. 
Application of EBP Model to DNP Project 
 The ACE Star Model was easily applied to the Doctor of Nursing Practice (DNP) EBP 
project process. Discovery research involved rigorously searching available literature related to 
the problem of interest, STD screening. Evidence summary involved critically appraising the 
relevant literature obtained by systematically reviewing scholarly databases. Translation to 
guidelines asked the doctoral student to evaluate how the literature coincides with nationally 
accepted guidelines, such as USPSTF and CDC, as well as organizational and personal goals. 
This required vital communication with key stakeholders. Practice integration required the 
doctoral student to determine how the proposed intervention needs to be implemented to 
promote healthy workflow. Finally, process/outcome evaluation asked the doctoral student to 
determine whether the evidence incorporated is effective and sustainable. This final step is 
considered dynamic and flexible, as needs may change over time and new evidence is 
constantly being introduced into practice. 
Strengths and Limitations of EBP Model for DNP Project 
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Strengths of the ACE Star Model included its similarity to the nursing process the 
doctoral student is inherently familiar with as well as its applicability on an individual and 
organizational level. An abundance of literature identified in the discovery and evidence 
summary stages provided a variety of best practice interventions to improve upon the clinical 
problem. Given national clinical guidelines call to increase chlamydia and gonorrhea screening 
rates among women 15 to 24 years old, translation to guidelines provided significant foundation 
to solidify the need to change practice. Limitations included the vagueness in describing 
strategies to promote successful integration into practice at the project site (i.e. how to approach 
barriers related to organizational culture). Because of the nebulousness, there was little 
guidance for the evaluation of progress and outcome. Significant challenges were faced in 
terms of staff compliance to the screening initiatives and therefore likely deterred successful 
practice change.  
Literature Search 
Sources Examined for Relevant Evidence 
An exhaustive literature search was performed within several scholarly databases as 
well as via hand-searching and citation chasing. The following databases were systematically 
searched: Cochrane, Joanna Briggs Institute (JBI), CINAHL, and MEDLINE. Several keywords 
relevant to the PICOT question were utilized, until a “best search” was identified. Trialing 
multiple keywords was necessary to yield relevant articles. Boolean operators, truncation, and 
mesh terms were used as appropriate. Keywords and Boolean operators applied include: 
“sexually transmitted disease*,” “sexually transmitted infection*,” STD, STI, screen*, test*, 
“urine,” “young adult,” teen*, adolescen*, chlamydia, “chlamydia trachomatis,” gonorrhea, 
“neisseria gonorrhea,” “primary care,” “internal medicine,” “general practice,” “family practice,” 
“family medicine,” and “emergency department”. Limiters included 2009-2019, English 
language, and peer-reviewed. Please see Table 2.1 for the best and final literature search. JBI 
did not reveal any relevant evidence. MEDLINE provided some relevant evidence, but none 
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were selected for use. Cochrane and CINAHL each yielded two articles that were selected for 
use in this project.  
Inclusion criteria included articles addressing chlamydia and/or gonorrhea screening, 
screening targeting women, and outpatient office setting and emergency department (ED) 
setting. Articles that discussed at home screening, screening among special populations such 
as sex workers or college students, treating (vs. screening) for chlamydia and/or gonorrhea, and 
screening involving STDs other than chlamydia and/or gonorrhea were excluded.  
A hand search of the CDC website as well as the Journal of Adolescent Health and 
Sexually Transmitted Diseases periodicals was performed. The CDC website search yielded 
one high level piece of evidence which was deemed appropriate for this project. Three articles 
were then “citation chased” from this original article and selected for use. Many articles 
reviewed were pertinent in providing background data and discussion. Ultimately, a total of eight 
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Table 2.1.  
Final literature search 
Database Limiters Duplicates Yielded 
Evidence 
Abstracts 
Reviewed 
Evidence 
Selected 
Cochrane 2009-2019 2 166 7 2 
JBI 2009-2019 0 10 0 0 
CINAHL 2009-2019 
English 
Peer-reviewed 
0 48  8 2 
MEDLINE 2009-2019 
English 
Peer-reviewed 
4 188 2 0 
Hand 
Searched 
N/A 0 3 3 1 
Citation 
Chased 
N/A 0 3 3 3 
Total N/A 6 418 21 8 
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articles were selected to provide a thorough literature review and develop the intervention for 
this doctoral project. 
Levels of Evidence  
 The John Hopkins Nursing Evidence-Based Practice Research Appraisal Tool was used 
to level the evidence. This tool ranks evidence on a hierarchy level I to III, with I being the 
highest level and level III being the lowest level (Dang & Dearholt, 2017). Level I constitutes a 
randomized controlled trial (RCT) or experimental study. Level II is a quasi-experimental study. 
Level III is a nonexperimental study. A checklist with a series of questions leads the reader to 
determine the level of evidence. Questions to level a single research study involve identifying an 
independent variable, a control group, and presence of absence of randomization (Dang & 
Dearholt, 2017). With regard to systematic reviews and meta-analyses, the questions serve to 
identify the type of studies summarized in order to determine level. 
 Four of the eight pieces of evidence were rated as Level I evidence. Three of the eight 
pieces of evidence were rated as Level II evidence due to lack of randomization or quasi-
experimental design. One of the eight pieces of evidence was rated as Level III as it is a 
systematic review that summarized RCTs (high level) and observational studies (low level). 
Please see table 2.2, which provides the level of each piece of evidence. 
Appraisal of Relevant Evidence 
The John Hopkins Nursing Evidence-Based Practice Research Appraisal Tool was used 
to appraise the evidence selected. This tool asks a series of questions and guides the reader to 
provide a recommendation of high quality (A), good quality (B), or low quality (C) (Dang & 
Dearholt, 2017). The tool asks the reader to inquire about the purpose of the study, literature 
review, sample size, study design, data collection and statistical analyses, results, and 
discussion of limitations, and conclusion. High quality (A) evidence provides consistent, 
generalizable results from a well-designed, controlled study (Dang & Dearholt, 2017). Good 
quality (B) evidence provides reasonably consistent results from a fairly-designed, controlled  
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Table 2.2.  
 
Evidence Summaries  
 
Citation 
(APA) 
Purpose Design 
 
Sample Measurement/ 
Outcomes 
 
Results/Findings Level/ 
Quality 
(DiVasta 
et al., 
2016) 
To increase 
chlamydia 
screening in at-
risk young 
women age 16-
24 y/o through 
EMR changes 
and learning 
communities 
(LC) 
Quality 
improvement 
project 
45 
intervention 
groups: 24 
from LC 1, 
21 from LC 
2 (EMR 
prompt to 
obtain 
sexual 
health 
history and 
learning 
communities 
focused on 
education r/t 
STD 
screening) 
 
40 control 
practices 
(EMR 
prompt to 
obtain 
sexual 
health 
history, NO 
additional 
education) 
 
Additional 
control 
included 
national 
data from 
Healthcare 
Effectivenes
s Data and 
Information 
set (HEDIS) 
 
Difference in 
Chlamydia 
screening 
rates pre-
intervention, 
post-EMR 
intervention, 
and post-LC 
intervention 
compared with 
control group 
rates pre-
intervention 
and post-EMR 
intervention as 
well as 
national data 
reflecting 
chlamydia 
screening rate 
trends 
LC 1: pre-intervention 
– 52.8%, post EMR 
intervention – 54.5% , 
post LC completion – 
66.7% 
 
LC 2: pre-intervention 
– 57.8%, post EMR 
intervention – 61.5% , 
post LC completion – 
69.3% 
 
Control: pre-
intervention – 58.3%, 
post EMR intervention 
– 66.1% 
 
HEDIS showed a lack 
of national trend of 
increasing chlamydia 
screening during study 
period 
II/B 
(Goyal et 
al., 2017) 
To assess 
whether a 
clinical decision 
support tool, 
Single-blind, 
2-arm, 
randomized 
720 patients 
14-19 years 
old: 367 
were 
STI testing 
frequencies 
between the 
intervention 
323 from the 
intervention arm and 
312 from the usual arm 
had evaluable data 
I/B 
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utilizing 
computerized 
STD risk 
assessments, 
would increase 
STDs 
(chlamydia/gono
rrhea) testing of 
adolescents at 
high risk for 
STDs in the 
emergency 
department (ED) 
 
controlled 
trial 
randomized 
into the 
intervention 
arm and 353 
to the usual 
care arm 
and usual 
care arms for 
the entire 
cohort as well 
as 
asymptomatic 
participants 
screened at 
high risk for 
STIs 
 
Significant increase in 
STI testing frequency 
among the intervention 
arm for the entire 
cohort and the 
asymptomatic high-risk 
groups 
(Guy et 
al., 2011) 
To review the 
effect of 
interventions on 
chlamydia 
screening rates 
or total tests 
Systematic 
review 
16 
intervention
s pulled 
from 11 
RCTs and 5 
observation
al studies 
targeting 
men only, 
women only, 
and both 
men and 
women 
Interventions 
to improve 
Chlamydia 
screening with 
screening 
rates or total 
tests 
6/15 interventions were 
significantly associated 
with increased 
chlamydia screening 
among women 
(multifaceted QI 
program, educational 
in-service, free sexual 
health visits, specimen 
collection with PAP, 
computer alerts) 
 
2/6 interventions were 
significantly associated 
with increase 
chlamydia screening 
among men (universal 
urine STD screening, 
multifaceted QI project) 
 
Of 5 interventions 
targeted for women 
and men, 4/5 and 1/5 
demonstrated a greater 
associated increase in 
chlamydia screening 
among men (incentive, 
education, QI) 
compared to women 
and men compared to 
women (QI), 
respectively 
 
III/A 
(Kettinger, 
2013) 
To determine if a 
tailored, 
multicomponent 
practice 
Pre/post 
intervention 
quality 
133 medical 
records pre-
intervention 
and 130 
Pre/post 
intervention 
screening and 
Pre-
intervention=53.4% 
screened for 
II/A 
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intervention 
results in 
increased 
chlamydia 
screening for 
nonpregnant, 
sexually active 
women 25 y/o or 
younger 
 
improvement 
project 
women 
post-
intervention: 
nonpregnant 
women, 25 
y/o or 
younger 
testing rates 
for chlamydia 
chlamydia/44.4% 
received testing 
Post-
intervention=76.1% 
screened for 
chlamydia/64.6% 
received testing 
(Lawton et 
al., 2010) 
To assess 
feasibility of an 
incentivized 
program to 
increase 
chlamydia 
screening in 
general practice 
Pilot study 
for 
randomized 
controlled 
trial 
3 practices 
(2 
intervention, 
1 control) in 
Wellington 
with 756, 
712, and 
936 male 
and female 
patients 
between 16-
24 y/o, 
respectively 
Change in 
chlamydia 
testing rates in 
the 
intervention 
groups (one 
nurse-led and 
one doctor-led 
that included 
staff 
compensation, 
education for 
staff and 
patients, 
offering 
testing, 
collecting 
specimen, f/u) 
compared to 
control group 
over 6 months 
Practice A (nurse-led 
intervention): 
Significant increase in 
testing rates in the first 
and second month, 
followed by a steady 
decline back to 
baseline 6 months post 
intervention; similar 
rates between men 
and women 
 
Practice B (doctor-led 
intervention): 
Significant increase in 
testing rates in the first 
and second month, 
followed by a steady 
decline back to 
baseline 6 months post 
intervention; screening 
rates lower among 
men 
 
Practice C (control): No 
change 
 
I/B 
(McNulty 
et al., 
2014) 
 
To evaluate 
whether a 
structured 
complex 
intervention 
increase 
chlamydia 
screening rates 
among patients 
aged 15-24 
years attending 
English general 
practices (GP) 
Prospective, 
cluster 
randomized 
controlled 
trial with a 
modified 
Zelen design 
15-24 year 
old patients 
at 76 
intervention 
practices 
and 76 
control 
practices in 
South West 
England 
Intention to 
treat  
(absolute 
testing rates 
among all 
practices 
studied), per 
protocol 
(testing rate of 
full 
intervention 
practices 
compared to 
control 
Intention to treat: 
greater increase 
among intervention 
practices compared 
with control practices; 
absolute testing rates 
of 15-24 year-old 
patients among 
intervention practices 
was increased, but 
marginal; practices in 
upper quartile of 
testing were more 
likely to have used 
I/B 
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practices), 
number of CT 
detected 
invitation cards, 
posters, and prompts 
 
Per protocol: 2.33 
times increased testing 
rate compared to 
control practices 
 
Number of CT 
detected: greater 
increase in detection 
rates among 
intervention practices; 
detection 1.8 times 
greater among per 
protocol (full 
intervention) practices 
compared to control 
practices 
 
(Taylor, 
Frasure-
Williams, 
Burnett, & 
Park, 
2016) 
 
To identify 
interventions 
that improve 
chlamydia/gonor
rhea/syphilis 
screening in 
community-
based clinics 
while 
considering cost 
and resources 
Meta-
Analysis 
42 
intervention
s pulled 
from RCTs, 
NRCTs, 
intervention
al and 
controlled 
observation
al studies 
that 
described 
clinic-based 
intervention
s for STD 
screening 
Difference in 
target 
population 
screened, cost 
analysis, and 
combined 
effectiveness 
and cost 
Difference in target 
population screening: 
Of 42 interventions, 16 
were rated as highly 
effective in increasing 
STD screening, 14 
were moderately 
effective, and 12 were 
not effective 
 
Cost analysis: 28 
intervention were less 
than $1K, 7 were 
between $1K-10K, 4 
were between $10K-
100K, 3 were $100L 
 
Combined effect and 
cost: automatic 
collection at visits and 
use of patient 
reminders were most 
cost effective 
 
II/A 
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(Tebb, 
Wibbelsm
an, & 
Nauhas, 
2009) 
To develop and 
evaluate an 
intervention to 
increase 
chlamydia 
screening 
among sexually 
active 
adolescents 
during pediatric 
urgent care visits 
Randomized 
controlled 
trial 
10 general 
pediatric 
clinics (5 
intervention, 
5 control) in 
northern 
California, 
adolescent 
girls 14-18 
y/o 
Difference in 
clinic specific 
proportions of 
adolescents 
screened 
Clinical specific 
proportions of 
adolescents screened 
were significantly 
greater post-
intervention among 
intervention vs. control 
groups 
I/A 
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study with fairly definitive conclusions. Low quality (C) evidence consists of an insufficient 
sample size, little evidence, or lack of definitive conclusions. 
Four pieces of evidence were appraised as grade A, while the remaining four pieces of 
evidence were appraised as Grade B. Please see table 2.2 for evidence summaries with 
provided appraised quality. 
Level I evidence. 
 Goyal et al. (2017) conducted a single-blind, two-arm RCT that assessed whether a 
clinical decision support tool would increase chlamydia and gonorrhea testing of adolescents in 
the ED setting. The clinical decision support tool started by assessing STD risk through a 
validated sexual risk assessment tool. Their responses categorized them as either low risk, at 
risk, or high risk. Based on their risk, the attending physician received a printed report 
recommending screening. Urine samples were collected and tested for chlamydia and 
gonorrhea on all patients, regardless if it was clinician ordered (as clinician failure to 
recommend screening was an expected limitation of the study).  
Of the 720 participants ages 14 to 19 years old, 367 were randomized into the 
intervention arm and 352 were randomized the usual care arm. Patients in the intervention arm 
for the entire cohort (low risk, at risk, and high risk) were more likely to be tested for STDs than 
the usual care arm cohorts (OR 1.5 [95% CI, 0.9-2.6]) (Goyal et al., 2017). When adjusted for 
age and gender, the significance remained (aOR 2 [95% CI, 1.1-3.8]). Approximately 69% of 
patients who screened positive for chlamydia or gonorrhea underwent clinician-ordered testing, 
which speaks to the benefit of automatic collection of urine. This experimental study is level I, 
high quality (A) evidence. 
 Lawton et al. (2010) conducted a pilot study for a RCT that evaluated the feasibility of an 
incentivized program to increase chlamydia screening among patients ages 16 to 24 years old 
in a general practice setting. The sample consisted of one nurse-led intervention practice, one 
doctor-led intervention practice, and one control practice with 756, 712, and 936 patients, 
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respectively. The intervention consisted of staff compensation for screening, staff and patient 
education on screening recommendations, periodic staff meetings to provide feedback and 
coaching, offering testing to all patients with self-collected vaginal swabs (for women) and/or 
urine for testing (for men and women), and providing appropriate follow up care. 
 Pre-intervention chlamydia screening rates were similar among each practice. Both the 
nurse-led and doctor-led interventions practices experienced an increase in chlamydia 
screening rates compared to the control practice (p<0.001) (Lawton et al., 2019). The nurse-led 
intervention practice demonstrated a greater increase than doctor-led intervention practice 
(p=0.04). Unfortunately, each intervention practice experienced a steady decline to pre-
intervention screening rates at the end of the six-month period. Due to lack of sustainability, this 
experimental study is level I, good quality (B). 
 McNulty et al. (2014) conducted an RCT that evaluated whether a structured, complex 
intervention increased chlamydia testing rates among patients age 15 to 24 years old attending 
a general practice. This study encompassed 76 intervention practice and 76 control practices in 
South West England. The complex intervention was based on the Theory of Planned Behavior 
(TPB) consisted of an outreach educational workshop with posters, invitation cards for patients, 
targets and feedback of practice testing performance with optional ongoing support. Staff 
attendance at the education varied and 13 practices refused any contact from a chlamydia 
support worker. Absolute testing among intervention practices was 1.76 times greater than 
control practices during the intervention period (p<0.001). In fully engaged practices, testing 
increased 2.33 times more than seen in control practices (p<0.001). This experimental study is 
level I, good quality (B) evidence due to inconsistency and some ambiguity in reporting 
statistical significance. 
 Tebb, Wibbelsman, and Nauhas (2009) conducted a study to develop and evaluate an 
intervention to increase chlamydia screening among sexually active adolescents ages 14 to 18 
years old during pediatric urgent care visits in Northern California. Ten pediatric clinics were 
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randomly assigned to intervention and control groups. Intervention groups formed a team of 
staff who determined the most efficacious ways (i.e. developing a protocol, automatically 
collecting a urine sample from those who reported sexual activity, alerting the provider that the 
adolescent may be eligible for testing, etc.) to identify sexually active teens then collect urine 
samples for testing. Controls received one informational lecture on chlamydia screening. The 
proportion of adolescent girls screened among the intervention group were significantly greater 
than the control group (p=<0.001). This experimental study is level I, high quality (A) evidence. 
 Level II evidence. 
 DiVasta et al. (2016) provided insight on a quality improvement project aimed at 
increasing chlamydia screening among at-risk women age 16 to 24 years old through EMR 
changes and learning communities. A total of 85 primary care offices within the Boston’s 
Children Hospital network opted to participate. Two learning community intervention groups 
were formed; 24 groups were assigned to learning community 1 (LC1) and 21 groups were 
assigned to learning community 2 (LC2). The remaining 40 groups were assigned to the control. 
LC 1 and LC2 consisted of four in-person educational session and two webinars that included 
content related to chlamydia screening, concerns surrounding legal issues and confidentiality, 
skills building, motivational interviewing, data review, case discussions, etc. Both LC groups and 
the control groups underwent changes in the EMR that prompted providers to collect sexual 
histories.  
LC1, LC2, and controls experienced an increase in screening rates post-EMR and pre-
LC intervention – 1.7% (95% CI, 0.1-3.2), 3.7% (95% CI, 2.0-5.3), and 7.8% (95% CI, 6.8-8.9), 
respectively (DiVasta et al., 2016). Post-EMR and post-LC intervention, both LC1 and LC2 
experienced further increases in screening rates – 13.9% (95% CI, 13.0-14.8) and 11.5% (95% 
CI, 9.8-13.2), respectively. Overall data were compared to HEDIS, which did not show a 
national trend of increasing chlamydia screening during the study period. This experimental 
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study is level II, good quality (B) evidence based on lack of randomization into cohorts (solely 
participatory) and inability to disentangle the effects of EMR changes and LC participation.  
 Kettinger (2013) described a pre and post-intervention quality improvement project 
aimed at increasing chlamydia screening among nonpregnant, sexually active women less than 
25 years old. One-hundred and thirty-three records pre-intervention were compared with 130 
women post-intervention at a women’s health practice in the Southern United States. In-
services were held separately for providers and nursing staff to educate on chlamydia screening 
(national recommendations, feasibility, overcoming barriers). A screening policy was put in 
place to flag providers to screen sexually active women less than 26 years old. Specimens were 
collected with urine or vaginal swab (if pelvic exam was to be performed). Pre-intervention, 
53.4% of women were screened and 44.4% received testing (p<0.05). Post-intervention, 76.1% 
of women were screening and 64.6% received testing (p<0.05). This quality improvement 
project, given its experimental nature, is level I, high quality (A) evidence.  
Taylor, Frassure-Williams, Burnett, and Park (2016) provided a meta-analysis reviewing 
interventions that improve chlamydia, gonorrhea, and syphilis screening in community-based 
clinics. These researchers pulled 42 interventions from RCTs, non-RCTs, interventional, and 
controlled observational studies that described clinic-based STD screening interventions. 
Secondary analysis was conducted to determine cost-effectiveness of the interventions. Among 
the most effective interventions included automatic collection of specimens for testing during a 
routine or follow up visit, reminders in the EMR, patient reminders, and utilization of dedicated 
staff members to promote screening. Patient and provider education showed limited 
improvement, whereas motivational counseling and interviewing showed minimal improvement. 
Automatic collection of specimens for testing, EMR, and patient reminders were most cost-
effective, while dedication of staff to promote screening was least cost-effective. Given this 
meta-analysis included a review of experimental and quasi-experimental studies, it is 
considered level II, high quality (A) evidence. 
INCREASING CT AND NG SCREENING  20 
 
 Level III evidence.  
 Guy et al. (2011) provided a systematic review that evaluated the effects of 16 
interventions on chlamydia screening rates or total tests. Interventions were detailed among 
RCTs and observational studies. Six of 15 interventions were significantly associated with 
increased chlamydia screening among women and included quality improvement programs, 
educational in-service, free sexual health visits, specimen collection with Papanicolaou, and 
computer alerts (p<0.05). This evidence was deemed level III due to inclusion of observational 
studies and rated high quality (A).  
Construction of Evidence-based Practice 
Synthesis of Critically Appraised Literature  
 Staff education and involvement. 
 With the exception of Goyal et al. (2017), each piece of evidence associated staff 
education and involvement with increased STD screening (DiVasta et al., 2016; Guy et al., 
2011; Kettinger, 2013; Lawton et al., 2010; McNulty et al., 2014; Taylor, Frassure-Williams, 
Burnett, & Park, 2016; Taylor, Frassure-Williams, Burnett, & Park, 2016; Tebb, Wibbelsman, & 
Neuhaus, 2009). Each article detailed varying duration and extensiveness of education. Three 
studies described focus group education as part of quality improvement projects to create 
protocols for testing at risk individuals (Kettinger, 2013; Guy et al., 2011; Tebb, Wibbelsman, & 
Neuhas, 2009). Varying depth of provider education showed improvement in screening rates 
across four studies. Taylor, Frassue-Williams, Burnett, & Park (2016) provided little detail on the 
degree of provider education and ultimately found limited improvement with this approach. 
Three articles described intensive provider education, with in-person education and/or webinars 
to communicate significance and approaches to screening (DiVata et al., 2016; Lawton et al., 
2010; McNulty et al., 2014). Lawton et al. (2016) incorporated periodic staff meetings to discuss 
progress. McNulty et al. (2014) utilized “champions” who were staff trained to encourage and 
provide ongoing support for screening. 
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Regardless of approach, they each reached similar conclusions. A common theme 
emerged and asserts that clinicians and support staff need to be educated on the screening 
guidelines. It was also found that barriers to screening and means to approach communication 
about screening should be included in education. 
 Routine screening. 
 Four of the eight articles reviewed recommended routine screening of the target 
population based on clinical guidelines (Goyal et al., 2017; Kettinger, 2013; Lawton et al., 2010; 
Tebb, Wibbelsman, & Neuhaus, 2009). Goyal et al. (2017), Kettinger (2013), and Tebb, 
Wibbelsman, and Neuhaus (2009) discussed incorporating a policy to screen women under 25 
years of age for sexual activity and recommending testing only if sexually active. This screening 
was either clinician driven or support staff driven. Lawton et al. (2010) recommended offering 
testing without screening for sexual activity, but rather based on age (16-24 years old) alone. 
 Automatic collection of specimens. 
 Three pieces of evidence recommended automatic collection of specimens with either 
urine testing or provider or patient collected vaginal swab (Guy et al., 2011; Tebb, Wibbelsman, 
& Neuhaus, 2009; Taylor, Frassure-Williams, Burnett, & Park, 2016). Guy et al. (2011) included 
chlamydia screening with all pap smears and fist-catch urine sample with any woman who fell 
between the ages of 16-25 years old. Tebb, Wibbelsman, & Neuhas (2009) collected sexual 
histories and offered urine screening for chlamydia. Taylor, Frassure-Williams, Burnett, & Park 
(2016) found that strategic placement of specimens for testing (i.e. with pap smear) and 
automatic collection of urine improved screening rates. Each noted routinely collecting 
specimens among the target population, regardless of sexual history. 
 EMR reminders. 
 Four articles spoke to EMR reminders as a proven means to increase STD screening 
(DiVasta et al., 2016; Goyal et al., 2017; Guy et al., 2011; Taylor, Frassure-Williams, Burnett, & 
Park, 2016). DiVasta et al. (2016) and Taylor, Frassure-Williams, Burnett, & Park (2016) used 
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the EMR to simply remind providers to screen adolescents and young adults. Guy et al. (2011) 
utilized an EMR reminder to screen based on age (16-24 years old). Goyal et al. (2017) 
incorporated a more complex intervention that included a built-in decision support tool that 
guided providers to screen and recommend testing based on risk for infection. Each 
demonstrated an increase in screening when EMR flagging was performed. This EMR flagging 
prompted the provider to screen for chlamydia and/or gonorrhea based on age.  
Best practice model recommendation 
 After reviewing the available literature, it was determined a combination of two best 
practice approaches, education and routine screening, would be appropriate for this doctoral 
project. The first intervention included provider and CMA education. A one-hour in-service was 
provided prior to the intervention period to discuss importance of screening for chlamydia and 
gonorrhea in the target population, national guideline recommendations, barriers to and 
facilitation of screening, routine sexual history taking, and collection of specimens. The second 
intervention occurred during the post-intervention period and involved routine sexual history 
taking by the CMAs. They were requested to ask the target population about sexual activity. If 
the patient noted that she was or had been sexually active, the CMA automatically offered 
testing per the providers’ recommendations. Urine specimens were collected for chlamydia and 
gonorrhea testing. 
 It is important to note that while EMR reminders were shown to improve screening rates, 
this is current practice at the project site and, to date, has been ineffective. The EMR specialists 
additionally notified the doctoral student that flagging options could not be changed and 
therefore this intervention could not be manipulated to be made more effective. 
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CHAPTER 3 
IMPLEMENTATION OF PRACTICE CHANGE  
Young women, less than 25 years old, account for the highest rates of chlamydia and 
gonorrhea nationwide (CDC, 2017b). In 2017, women 15 to 24 years old made up 62.6% of new 
chlamydia cases, or 3,635.3 cases per 100,000 people (CDC, 2017b). Additionally, women 15 
to 24 years old accounted for 622.8 cases of gonorrhea per 100,000 people. USPSTF 
recommends screening all sexually active females less than 25 years old for chlamydia and 
gonorrhea annually (2014). Given the magnitude of the issue, a goal of Healthy People 2020 is 
to increase the proportion of sexually active women 24 years old and younger for chlamydia 
(HHS, Healthy People 2020, 2019). This project served to increase chlamydia and gonorrhea 
screening among sexually active, nonpregnant females between 15 and 24 years old within the 
primary care setting in order to identify infection and appropriately reduce burden of disease. 
To reiterate, this doctoral project served to answer the following PICOT question: Among 
sexually active, nonpregnant women 15 to 24 years old (P), how does colleague education, 
routine sexual history taking, and subsequent collection of urine specimen for sexually active 
women (I) compared to no standard practice (C) improve chlamydia and gonorrhea screening 
uptake (O) over a 10-week period (T)? 
 Evidence has shown educational interventions aimed at promoting awareness among 
staff, asking the difficult question about women’s sexual activity, and recommending testing as 
indicated by a positive response increases identification and treatment of chlamydia and 
gonorrhea. Details regarding the tailored intervention for this project are outlined below. This 
practice change occurred over a 10-week period between August 26th, 2019 and November 4th, 
2019. 
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Participants and Setting  
The setting for this doctoral project was a two-provider family practice in Bristol, Indiana. 
The practice is a part of a larger health system in Goshen, Indiana. This family practice setting 
serves patients from the greater Elkhart and St. Joseph counties as well as southern Michigan. 
Providers see patients across the lifespan. Women’s health services, excluding antenatal care, 
is provided that includes placement of intrauterine devices (IUD). 
The doctoral student is a Family Nurse Practitioner (FNP) at this location and has been 
in this capacity for over two years. The doctoral student’s collaborating physician has over 25 
years of experience in family medicine and has been practicing with this organization for over 15 
years. Three certified CMAs, with varying years of experience, provide direct care to patients at 
this practice. All mentioned providers and colleagues participated in this project.  
 The patient population involved in the practice change included sexually active females 
between 15 and 24 years old presenting for preventive visits (well child/well adult or well woman 
exam) and/or contraceptive counseling/management. Ineligible patients included men, females 
presenting specifically for acute concerns including issues pertaining to the urogenital system, 
pregnant females, females 25 years and older, mentally disabled females, and incarcerated 
females. 
Pre-Intervention Group Characteristics 
 Pre-intervention group characteristics were obtained via EMR audit 10 weeks prior to the 
intervention period. This was successful due to aid of the facility’s EMR specialist, who assisted 
in extracting the data. Data were manually checked for patient eligibility and accuracy. There 
were 18 female patients between 15 and 24 years old that presented for preventive and/or 
contraceptive related visits and were deemed eligible for the intervention. Demographics, 
including age, insurance, race, and marital status were reviewed. Of these 18 females, over half 
were minors.  Approximately 61% females were white or Caucasian, 11% were black or African 
American, and 28% were Hispanic. With regard to insurance coverage, over half were insured 
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through Medicaid compared to commercially insured. All participants reported being single. 
There was one positive chlamydia infection and one positive gonorrhea infection identified. 
Intervention  
In preparation for this multifaceted intervention, two items were prepared by the doctoral 
student. The first involved altering a chart preparation sheet that the CMAs use to anticipate the 
needs of each patient during his or her visit. This information largely consists of screening 
needs in relation to care guidelines. Examples include immunizations, colonoscopy, 
mammography, etc. Previously, there was not a place that included chlamydia and gonorrhea 
screening recommendations for the target population. Adjustments were made to account for 
this screening. Please see Appendix A and B for chart preparation documents – adult and 
pediatrics. 
The second piece of preparation involved creating a PowerPoint presentation (Appendix 
C) addressing the following key points: 
 Background information 
 National, state, and county incidence of chlamydia and gonorrhea 
 Current screening rates nationally (HEDIs reporting), regionally (Elkhart County 
Health Department reporting), and practice specific (via retrospective chart audit) 
 Current recommendations published form USPSTF (2014) to screen all sexually 
active females 15 to 24 years old for chlamydia and gonorrhea 
 Healthy 2020 goal of increasing proportion of sexually active females 15 to 24 
years old screened for chlamydia (HHS, Healthy People 2020, 2019). 
 Collecting information at preventive and contraceptive visits 
 Prompting screening to those who are sexually active 
 Exclusion of patients presenting for genitourinary concerns (i.e. those who are 
symptomatic) 
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A key element of this presentation was communicating the delegation of sexual history taking to 
the CMAs. The CMAs serve as gatekeepers in obtaining pertinent information that would direct 
preventive screening efforts. They were requested to ask any female 15 to 24 years old during a 
preventive or contraceptive related visit if she is sexually active. Sexually active could be by 
means of oral, vaginal, and/or anal sex. If the female responds yes, the CMA recommended 
screening via urine sample. Women who presented with potential symptoms of STD (vaginal 
discharge, dysuria) were excluded as this becomes diagnostic vs. screening. The provider 
shared the responsibility of reviewing information collected by the CMAs and providing rationale. 
A 30-minute in-service was provided to communicate the clinical problem and provide guidance 
on prompting screening. The remainder of the intervention was then initiated Monday, August 
26th, 2019. 
Comparison   
Ten weeks leading up to the intervention period (June 14th to August 23rd), both 
providers at the practice saw 18 females between 15 and 24 years old for preventive exams or 
contraceptive related visits. None of these females presented with urogenital complaints. Of the 
18 females evaluated, 11 were screened for sexual activity, five were eligible for testing based 
on sexual activity, and four were tested for chlamydia and gonorrhea. This equates to a 61 % 
percent screening rate, which is on par with the NCQA (2019) HEDIS managed health and 
commercial reported screening rates of 50-60%. Regardless, screening rates could be 
improved. Given the mean age of vaginal intercourse among females is 17.3 years old (CDC, 
2017c), half of adolescents between ages 15 and 19 years old report ever engaging in oral sex 
(Copen, Chandra, & Martinez, 2012), and less than or equal to one-third of sexually active 
people ages 15 to 44 years old reported condom use with last intercourse (Copen, 2017), it is 
highly likely that necessary screening is vastly underperformed and many infections exist under 
the radar. 
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Prior to this project, there was no standard practice for obtaining sexual histories among 
this population. There was inconsistency among the EMR flagging system to screen for 
chlamydia based on current guidelines. Additionally, screening for gonorrhea was not included 
in the EMR flagging system, which is out of alignment with current guidelines. 
Outcomes  
 The primary outcome this project evaluated included number of patients screened for 
sexual activity, eligible for chlamydia and gonorrhea testing based on sexual activity, and tested 
for chlamydia and gonorrhea among the target population post-intervention. A secondary 
outcome under investigation included number of positive chlamydia and gonorrhea results as a 
result specimen collection. Demographic characteristics including age ranges 15 to 17 years old 
and 18 to 24 years old, insurance, race, and marital status were evaluated pre- and post-
intervention to identify similarities and differences among the pre-intervention and post-
intervention participants.  
 Pre- and post-intervention data collection involved retrospective chart review. 
Information pertaining to demographic information, inquiry regarding sexual activity, 
documentation of testing for chlamydia and gonorrhea via Current Procedural Terminology 
(CPT) codes (see table 3.1) and results of chlamydia and gonorrhea screening via manual audit 
were extracted via assistance of the EMR specialist. The EMR specialist was able to generate 
and connect such information by submitting a footprint request to the EMR development team 
with required age ranges and International Classification of Diseases (ICD) codes (see table 
3.2). This information was additionally audited by the doctoral student by manually extracting 
data from the EMR. 
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Table 3.1.  
 
Preventive and Contraceptive ICD codes 
 
ICD 10 code Diagnosis description 
T38.4X5A Adverse effect of oral contraceptives 
T83.9XXA IUD complication 
Z00.00 General medical examination, annual 
physical exam, health examination 
Z00.01 Routine health exam, health maintenance 
exam 
Z00.121 Well child exam 
Z00.12 Well child exam 
Z01.411 Well women/gynecologic exam with abnormal 
findings 
Z01.419 Well women/gynecologic exam with normal 
findings 
Z02.5 Sports physical 
Z11.3 Screening for sexually transmitted disease(s) 
Z12.4 Cervical cancer screening, encounter for 
Papanicolaou smear 
Z30 (all codes) Initial prescription/surveillance of 
contraceptive methods 
Z53.8 Unsuccessful IUD insertion/removal 
Z78.9 Other specified health status 
Z97.5 Presence of IUD 
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Table 3.2.  
 
CPT Code for Urine CT and NG Testing 
 
CPT code Test Specimen Source 
17305 CHLAMYDIA/N. 
GONORRHOEAE DNA, SDA 
Urine 
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Statistical analyses were performed to compare pre-intervention and post-intervention 
demographics, patients screened for sexual activity, patients eligible for testing based on sexual 
activity, patients tested for chlamydia and gonorrhea, and patients positive for chlamydia and/or 
gonorrhea. Chi-square analysis was utilized to identify differences among all previously 
mentioned nominal data. 
Time 
 The first step of the project began with a 30-minute in-service for the collaborating 
physician and four CMA colleagues on Friday, August 23rd, 2019. The site manager, also site 
facilitator, was also present. An hour of their time was blocked out to receive this information. A 
brief PowerPoint presentation outlining the purpose and dynamics of the intervention was 
developed and approved by the faculty supervisor prior to the in-service. Chart preparation 
documents were also updated prior to the in-service. This was approved by the collaborating 
physician, CMAs, and project facilitator. Monday, August 26th, 2019 the CMAs began asking 
eligible participants whether they are sexually active and offering urine chlamydia and 
gonorrhea testing if they indicated they were or had been sexually active. The project ran for 10 
weeks and was completed at the end of the work day Friday, November 1st, 2019. The timeline 
was developed to allow for successful completion as a longer time frame was desired to achieve 
an adequate sample size. 
Protection of Human Subjects  
Protection of human subjects was a vital component necessary to complete this doctoral 
project. Appropriate approval was obtained by the organization to participate in the doctoral 
project on site. Prior to initiation of the project, the doctoral student completed a doctoral level 
ethics course and completed basic ethics training through the Collaborative Institutional Training 
Initiative (CITI) (Appendix D). Information detailing the project components was provided to 
Valparaiso’s Institutional Review Board (IRB) and it was deemed exempt from IRB review. A 
formal application for IRB exemption was then processed and approved. The doctoral student 
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additionally met with Goshen Health’s IRB chair to determine necessary review on the 
organization’s end. Goshen Health’s IRB chair additionally approved the IRB exemption 
(Appendix E) and no further action was necessary from the organization’s standpoint. 
 All colleagues, including the doctoral student, at the project site were educated on and 
abide by organizational policies and procedures aimed at protecting patient confidentiality in 
accordance with the Health Insurance Portability and Accountability Act of 1996 (HIPAA). 
Appropriate consent for evaluating and treating minors without a parent (this only excludes 
vaccine administration) was kept on file in the patient’s chart (Appendix F). This was completed 
upon registration as a new patient at any of our organization’s outpatient offices and therefore 
was in place prior to any services being rendered. All colleagues were familiar with mandated 
reporting of positive chlamydia and gonorrhea results to the Elkhart County Health Department. 
Patients or guardians were made aware of this necessary reporting upon communication of a 
positive result. 
 The doctoral student extracted pre-intervention and post-intervention data with the 
assistance of the organization’s EMR specialists. All information was de-identified to protect the 
privacy of the patients. Information was extracted on the facility’s computer while logged into the 
facility’s secured network. While the doctoral student is a provider within the facility, she did not 
initiate the intervention requiring interaction with the participant. 
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CHAPTER 4 
FINDINGS 
This EBP project was designed to determine if a multifaceted intervention increased 
chlamydia and gonorrhea screening among nonpregnant women 15 to 24 years old, in 
accordance with USPSTF (2014) and CDC (2014c) clinical guidelines. Retrospective chart 
review was performed to collect demographics (age, insurance, race, marital status), number of 
women screened for sexual activity, number of women eligible for chlamydia and gonorrhea 
testing based on sexual activity, number of women eligible for testing that were tested for 
chlamydia and gonorrhea, and number of positive chlamydia and gonorrhea results of eligible 
participants throughout a 10-week pre-intervention and 10-week post-intervention period. 
There were nonsignificant increases in the number of women screened for sexual 
activity, number of women eligible for testing, and number of eligible women tested during the 
10-week post-intervention period compared with the 10-week pre-intervention period. There 
were no significant differences in demographics, number of positive chlamydia results, or 
number of positive gonorrhea results when comparing the 10-week pre-intervention group with 
the 10-week post-intervention group. 
Participants 
Size 
 Ten weeks pre-intervention, 18 eligible females presented to the clinic for either a well 
visit or contraceptive related visit compared with 14 eligible females during the 10-week post-
intervention period.  
Characteristics 
Demographic characteristics for participants in the pre-intervention and post-intervention 
(N=32) groups were analyzed using descriptive statistics via frequencies (Table 4.1). Majority of 
participants were between the ages of 15 and 17 years old pre-intervention (61%) and post- 
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Table 4.1.  
Demographics 
 
Demographic Frequency (%) 
Pre-intervention Post-intervention 
Age Range 15-17 y/o 11 (61%) 8 (57%) 
18-24 y/o 7 (39%) 6 (43%) 
Insurance Medicaid 10 (56%) 11 (79%) 
Commercial 8 (44%) 3 (21%) 
Race Caucasian/White 11 (61%) 8 (57%) 
AA/Black 2 (11%) 1 (7%) 
Hispanic/Latino 5 (28%) 3 (21%) 
Declined/Other 0 (0%) 2 (14%) 
Marital Status Single 18 (100%) 14 (100%) 
Married 0 (0%) 0 (0%) 
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intervention (57%), while 39% and 43% were between the ages of 18 and 24 years old in the 
pre-intervention and post-intervention groups, respectively (Figure 4.1, Figure 4.2). There were 
more participants insured through Medicaid in the pre-intervention (56%) and post-intervention 
(79%) groups compared with commercial insurers (44% and 21%, respectively) (Figure 4.3, 
Figure 4.4). In the pre-intervention group, 61% were white or Caucasian, 11% were black or 
African-American, and 28% were Hispanic or Latino (Figure 4.5). In the post-intervention group, 
57% were white or Caucasian, seven percent were black or African-American, 21% were 
Hispanic or Latino, and 14% were other races or declined to specify (Figure 4.6). All 32 
participants (100%) reported being single (Figure 4.7, Figure 4.8). 
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Figure 4.1.  
Age Range Pre-Intervention 
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Figure 4.2.  
Age Range Post-Intervention 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
57%
43%
Age Range Post-Intervention
15 to 17 Years Old 18 to 24 Years Old
INCREASING CT AND NG SCREENING  37 
 
Figure 4.3. 
 Insurance Pre-Intervention 
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Figure 4.4. 
 Insurance Post-Intervention 
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Figure 4.5.  
Race Pre-Intervention 
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Figure 4.6.  
Race Post-Intervention 
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Figure 4.7.  
Marital Status Pre-Intervention 
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Figure 4.8.  
Marital Status Post-Intervention 
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Changes in Outcomes 
Statistical Testing and Significance 
Primary outcomes of this EBP project included number of women screened for sexual 
activity, number of women eligible for testing based on sexual activity, and number of women 
eligible for testing that were tested for chlamydia and gonorrhea. Secondary outcomes included 
in this EBP project were number of positive chlamydia and gonorrhea results as a result of 
testing. 
 Data were entered into the Statistical Package for Social Sciences (SPSS) Version 25 
for analysis. Chi-square analysis was used to compare differences among pre-intervention and 
post-intervention participant demographics, number screened for sexual activity, number eligible 
for testing, number tested for chlamydia and gonorrhea, number positive chlamydia results, and 
number positive gonorrhea results. Statistical significance was set at p<.05 for all analyses. 
Demographics 
 Chi-square analyses revealed no significant difference in age (𝝌2(1, N=32)=.051, p>.05), 
insurance (𝝌2(1, N=32)=1.849, p>.05), race (𝝌2(3, N=32)=2.852, p>.05), or marital status (N/A 
– all participants in each group were single) of participants in the 10 week pre-intervention group 
compared with participants in the 10 week post-intervention group.  
Primary Outcomes 
 There were nonsignificant increases in the number of women screened for sexual 
activity, number of women eligible for testing, and number of women tested for chlamydia and 
gonorrhea. Results are displayed in Table 4.2 and Figure 4.9. 
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Table 4.2.  
Primary Outcomes 
Outcome Frequency (%) 
Pre-Intervention Post-Intervention 
Screened for Sexual 
Activity 
11 (61%) 11 (79%) 
Eligible for CT/NG Testing 5 (45%) 7 (64%) 
Tested for CT/NG 4 (80%) 7 (100%) 
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Figure 4.9.  
Pre- and Post-Intervention Sexual History Taking, Eligibility, and Testing (%) 
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Number of women screened for sexual activity. 
There was a nonsignificant increase in the number of women screened for sexual 
activity (𝝌2(1, N=32)=1.117, p>.05). Sixty-one percent of women were screened for sexual 
activity in the pre-intervention group compared with 79% in the post-intervention group. 
Number of women eligible for testing.  
There was a nonsignificant increase in the number of women eligible for testing based 
on sexual activity (𝝌2(1, n=22)=0.733, p>.05). Forty-five percent of women were eligible for 
testing in the pre-intervention group compared with 63% in the post-intervention group.  
Number of women tested for chlamydia and gonorrhea.  
There was a nonsignificant increase in the number of women tested for chlamydia and 
gonorrhea (𝝌2(1, n=12)=1.527, p>.05). Eighty percent of eligible women were tested for 
chlamydia and gonorrhea in the pre-intervention group compared with 100% in the post-
intervention group. 
Secondary Outcomes 
 Number of positive chlamydia results.  
 There was no significant difference in the number of positive chlamydia results (𝝌2(1, 
n=12)=1.527, p>.05). There was one positive chlamydia result within each group (20% vs. 14% 
pre-intervention and post-intervention, respectively) (Table 4.3). 
 Number of positive gonorrhea results.  
There was no significant difference in the number of positive gonorrhea results (𝝌2(1, 
n=12)=2.203, p>.05). There was one positive gonorrhea result within the post-intervention group 
(20% vs. 0% pre-intervention and post-intervention, respectively) (Table 4.3). 
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Table 4.3.  
Secondary Outcomes 
Outcome Frequency (%) 
Pre-Intervention Post-Intervention 
Positive CT 1 (20%) 1 (14%) 
Positive NG 1 (20%) 0 (0%) 
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CHAPTER 5 
DISCUSSION 
 This chapter serves to explain how a multifaceted intervention impacted chlamydia and 
gonorrhea screening among sexually active, nonpregnant women 15 to 24 years old over a 10-
week post-intervention period at a northern Indiana Family Medicine clinic. Findings will be 
integrated with the EBP model selected to guide the project. Strengths, limitations, and 
implications for the future will be elaborated. 
Explanation of Findings 
 While there was an increase in the percentage of women screened for sexual activity, 
women eligible for testing based on sexual activity, and women tested for chlamydia and 
gonorrhea, these increases were not significant (p>.05). Analysis of secondary outcomes 
showed no significant difference in the number of women tested that resulted positive for 
chlamydia or gonorrhea. 
 When considering available evidence to improve asymptomatic screening of chlamydia 
and gonorrhea, results of this EBP project were somewhat in alignment with available literature. 
This EBP project modeled Kettinger (2013) most similarly. Kettinger discussed an intervention 
that involved a one-time educational in-service for colleagues and implementing a flagging 
feature within the EMR. This flagging feature reminded colleagues (providers and support staff) 
to screen women less than 25 years old for sexual activity. Results of Kettinger’s intervention 
were significant (<0.05). While this EBP project was unable to alter the EMR flagging system, a 
chart preparation worksheet (Appendix A, Appendix B) was used as a substitution. 
 As mentioned, EMR modifications were substituted by utilization of a MA driven chart 
preparation document (Appendix A, Appendix B). DiVasta et al. (2016), Goyal et al. (2017), and 
Taylor, Frasure-Williams, Burnett, & Park (2016) cited EMR changes to remind colleagues and 
providers to screen and/or risk assess for chlamydia, gonorrhea, and/or syphilis exposure. 
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Tebb, Wibbelsman, & Nauhas (2009) discussed initiating a support staff driven protocol for 
screening eligible women and notifying providers about patients eligible for testing. Each article 
reported significant increases in testing rates. 
 Guy et al. (2011), Lawton et al. (2010), McNulty et al. (2014), Taylor, Frasure-Williams, 
Burnett, & Park (2016), and Tebb, Wibbelsman, & Nauhas (2009) incorporated educational in-
services (single or a series of in-services) as an effort to increase chlamydia, gonorrhea, and/or 
syphilis screening. Each article reported significant increases in testing, although Taylor, 
Frasure-Williams, Burnett, & Park, 2016 noted marginal increases in testing as a result of 
educational in-services. McNulty et al., 2014 noted increases in chlamydia detection rates, 
which was not evident in this EBP project. 
 Due to concerns that automatic collection of specimens for testing cited by Goyal et al. 
(2017), Guy et al., (2011), Tebb, Wibbelsman, & Nauhas (2009), and Taylor, Frasure-Williams, 
Burnett, & Park (2016) would violate the ethical principal of informed consent, this intervention 
was not used in this EBP project. By automatically collecting specimens without discussing with 
the patient, this could void privacy (i.e. a minor billed under parents’ insurance) or the patient 
could incur charges for testing she otherwise would have declined. Patients should be fully 
involved in their healthcare. This involves holding an evidence-based conversation to enable 
them to make informed decisions. Additionally, such diseases are required to be reported to the 
health department. It would be unethical to report a disease to the health department if the 
patient was never aware she was going to be tested for such disease. Leaving the patient out of 
the conversation places the patient and provider trust at significant risk. However, automatic 
collection of specimens noted in the evidence showed significant increases in each of these 
studies. Regardless, it was deemed inappropriate for inclusion in an EBP project for the 
aforementioned reasons. 
This EBP project sought to answer the following question: Among sexually active, 
nonpregnant women 15 to 24 years old (P), how does colleague education, routine sexual 
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history taking, and subsequent collection of urine specimen for sexually active women (I) 
compared to no standard practice (C) improve chlamydia and gonorrhea screening uptake (O) 
over a 10-week period (T)? The biggest caveat to asserting the EBP project results reflected 
available literature was the lack of significance. Results and relationship with the evidence will 
be explained further as outcomes are examined. 
Participants 
 Age range. 
 The highest rates of chlamydia and gonorrhea occur among people 15 to 24 years old 
(CDC, 2017b). In 2017, CDC reported the highest rates of chlamydia among women 19 and 20 
years old (2018). Guidelines surrounding annual chlamydia and gonorrhea screening target 
women less than 25 years old (CDC, 2014c; USPSTF, 2014). Unless consent (Appendix F) to 
treat a minor at the project site is on file at the project site, all minors must be accompanied by a 
parent or guardian. Therefore, data collection involved splitting participants into groups to 
evaluate differences in women presenting for preventive and/or contraceptive related visits 
based on minor status. While there were greater frequencies of minors who presented 
throughout the pre-intervention and post-intervention period, there was no significant difference 
in age range (15-17 years old vs. 18-24 years old) between the groups (p>.05). 
 Insurance. 
 A goal identified by Healthy People 2020 is to increase the proportion of sexually active 
women 24 years and younger enrolled in commercial and Medicaid plans who are screened for 
chlamydia (HHS, Healthy People 2020, 2019). Greater frequencies of Medicaid insured women 
compared to commercially insured women presented for preventive and/or contraceptive related 
visits in the pre-intervention (56% vs. 44%, respectively) and post-intervention groups (79% and 
21%, respectively). There was no significant difference in type of insurance when comparing 
pre-intervention and post-intervention groups (p>.05). 
 Race. 
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 There was no significant difference among race (Caucasian/White, African 
American/Black, Hispanic/Latino, other/declined) between the pre-intervention and post-
intervention groups (p>0.05). Between the pre-intervention and post-intervention groups, there 
were greater frequencies of Caucasian/White women (61% and 57%, respectively) compared to 
African American/Black women (11% and 7%, respectively). This raises the question of health 
disparities in preventive health care and contraceptive access for Black/African American 
women, especially considering the highest rates of chlamydia and gonorrhea occur among 
Black/African American women (CDC, 2017b). 
 Marital status. 
 Marriage is assumed to be monogamous, which should hypothetically mean little to no 
risk for contracting STDs. National clinical guideline recommendations do not exclude married 
women. Marital status was evaluated between the pre-intervention and post-intervention 
groups. Each participant reported being single, therefore statistical analyses were not 
performed. 
Primary outcomes 
 Number of women screened for sexual activity.  
 While there was an increase in the frequency of women screened for sexual activity 
when comparing pre-intervention (61%) and post-intervention (79%) groups, the results did not 
yield significance (p>.05). Kettinger (2013) modeled the EBP project design and reported 
significant increases in women screened for sexual activity. The results of this EBP project do 
not support that the multifaceted intervention increased the number of women screened for 
sexual activity. Small sample size pre-intervention (n=18) and post-intervention (n=14), short 
timeframe (10 weeks), and lack of colleague participation in the project likely contributed. 
 Number of women eligible for testing. 
 While there was an increase in the frequency of women eligible for testing based on 
sexual activity when comparing pre-intervention (45%) and post-intervention (64%) groups, the 
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results did not yield significance (p>.05). Results do not support that the multifaceted 
intervention increased detection of women eligible for testing. Small sample size pre-
intervention (n=18) and post-intervention (n=14), short timeframe (10 weeks), and lack of 
colleague participation in the project likely contributed. 
 Number of women tested for chlamydia and gonorrhea. 
 While there was an increase in the frequency of women tested for chlamydia and 
gonorrhea when comparing pre-intervention (80%) and post-intervention (100%) groups, the 
results did not yield significance (p>.05). Kettinger (2013) modeled the EBP project design and 
reported significant increases in women tested for chlamydia. The EBP project results do not 
support that the multifaceted intervention led to more women being tested for chlamydia and 
gonorrhea. Small sample size pre-intervention (n=18) and post-intervention (n=14) and short 
timeframe (10 weeks) likely contributed. Colleague participation is not to blame for results of this 
outcome given 100% of women who met criteria for testing were tested. Additionally, no women 
who were recommended testing declined.  
Secondary Outcomes 
 Number of positive chlamydia results.  
 There was no significant difference in chlamydia infections detected when comparing 
pre-intervention (20%) and post-intervention (14%) groups (p>.05). Given chlamydia usually has 
an asymptomatic presentation (CDC, 2014a), it was expected more infections would be 
detected with increase in testing. As previously noted, the increase in testing was not significant. 
Results likely were limited by small sample size pre-intervention (n=18) and post-intervention 
(n=14) and short timeframe (10 weeks). Results did not align with McNulty et al. (2014) who 
reported a significant increase in chlamydia detection rates as a result of their interventions. 
 Number of positive gonorrhea results.  
 There was no significant difference in gonorrhea infections detected when comparing 
pre-intervention (20%) and post-intervention (0%) groups (p>.05). Given gonorrhea usually has 
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an asymptomatic presentation (CDC, 2014b), it was expected more infections would be 
detected with increase in testing. However, as previously noted, the increase in testing did not 
yield significance. Results were likely limited by small sample size pre-intervention (n=18) and 
post-intervention (n=14) and short timeframe (10 weeks).  
Strengths and Limitations of the DNP Project 
Strengths 
A few strengths were noted throughout this project. One strength was that the EBP 
project was performed at the DNP student’s well-established practice. She had support of the 
organization including administration, her collaborating physician, IT, and clinical colleagues. 
She had access to resources that may have not been readily available for a student not 
employed by the clinical site. She was familiar with current practice and personally identified 
gaps in care surrounding this project.  
 Another strength involved the simplicity of the interventions. The DNP student was able 
to organize and facilitate a brief in-service to educate colleagues on the EBP project. The 
second part of the intervention involved altering workflow for clinical colleagues so women 15 to 
24 years old presenting for preventive and/or contraceptive related visits were screened for 
sexual activity. This aspect of the intervention involved changing a master document, namely 
chart preparation sheets (Appendix A, Appendix B) for the MAs. The MA would simply 
incorporate this into their health maintenance responsibilities and recommended urine testing if 
the woman indicated she was or has been sexually active. Overall, the concept for the MAs was 
very straightforward.  
 Several steps of the ACE Star Model (Stevens, 2012) utilized for this EBP project was 
shown to be congruent with the goals of the project. Four of the five stages of transformation 
were successfully applied to the EBP project. Discovery research and evidence summary was 
accomplished by the DNP student who brought forth the strongest evidence available 
supporting best practice interventions. Translation to guidelines was supported by known clinical 
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national guidelines to both providers – USPSTF and CDC.  Process and outcome evaluation is 
ongoing as both providers work toward making the practice change sustainable, recognizing 
there were several barriers along the way. Both providers are committed to changing practice 
and the organization supports ongoing quality improvement efforts. 
Limitations 
 Limitations were encountered throughout this project that may have impacted results. 
When considering the ACE Star Model (Stevens, 2012) that was used to guide the project, the 
step involving practice integration was not as successful as hoped due to high colleague 
turnover (one termination and two resignations) and reluctance to change workflow. One MA 
served as a change agent, but due to discourse among three other colleagues, the change 
agent was unsuccessful in shifting the other clinical colleagues’ perspectives. The colleagues 
unwilling and disinterested in committing the practice change noted a lack of time and feeling 
overwhelmed by daily schedules. Several times it was mentioned that they simply forgot to 
screen, despite utilizing the chart preparation documents (Appendix A, Appendix B). The 
physician colleague admitted he forgot to follow up on screening performed by the MA 
colleagues due to time constraints. 
Sample size may have contributed to lack of significant results. Sample sizes pre-
intervention (n=18) and post-intervention (n=14) were small. Considering volume of the two-
provider practice holding a combined practice panel of approximately 3,000 patients, 10 weeks 
was likely insufficient time to collect an adequate sample size. 
Implications for the Future 
Practice 
 Strong clinical guidelines assert screening sexually active females less than 25 years old 
for chlamydia and gonorrhea annually (CDC, 2014c; USPSTF, 2014). Several interventions, 
including those implemented in this project, are supported in literature as best practice 
interventions. While there are currently no plans to provide another colleague in-service related 
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to the clinical problem, the practice continues to use the chart preparation documents (Appendix 
A, Appendix B) that were modified for the EBP project. This chart preparation documents will 
continue to remind clinical colleagues to screen women for chlamydia and gonorrhea. 
Theory 
 Theoretical concepts and evidence-based practice models should continue to guide EBP 
projects. EBP models like the ACE Star Model (Stevens, 2012) help drive quality change by 
condensing volumes of research into evidence-based approaches that clinicals can employ. 
Further research surrounding screening efforts should incorporate social cognitive theories that 
focus on provider beliefs and practices. To date, behavioral theories like social cognitive theory, 
have been applied to primary prevention research (reducing high risk sexual behaviors) 
opposed to secondary prevention research that provided the foundation of this EBP project 
(CDC, 2012). 
Research 
 Further research on how to incorporate chlamydia and gonorrhea screening in a way 
that is perceived as time efficient would be beneficial. It was noted by the site physician and 
clinical colleagues that a lack of time and being behind schedule were barriers to screening 
women for sexual activity and thus making appropriate recommendations for testing. 
 Additionally, many interventions noted in the literature were effective. Interventions 
ranged from automatic collection of specimens for testing to series of educational sessions for 
colleagues or developing detailed policies and protocols. It would be useful to compare these 
interventions to determine superiority of one intervention over another. 
Education 
 Implications for education should focus on providers and clinical staff. This encourages 
more effort to ask the hard question surrounding sexual activity in order to identify females at 
risk of contracting chlamydia and gonorrhea. Providers in primary care practices should be 
briefed on the magnitude of the problem relating to chlamydia and gonorrhea incidence and 
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prevalence among patients less than 25 years old. They should be informed that people 
between 15 and 24 years of age acquire half of all new STDs and that one in four sexually 
active adolescent girls will acquire a STD (CDC, 2017b).  
Many providers are already aware, but should be reminded that majority of chlamydia 
and gonorrhea infections are asymptomatic (Ghanem & Tuddenham, 2018). Additionally, it is 
important to explain that recommendations surrounding chlamydia and gonorrhea screening set 
forth by USPSTF (2014) and CDC (2014c) focus on females less than 25 years old due to 
potential reproductive sequela such as chronic pelvic pain, miscarriage, and infertility (CDC, 
2014a; CDC, 2014b; Ghanem & Tuddenham, 2018). While intuitively it makes sense to screen 
men and women and providers should utilize their best judgement, the risks associated with 
chronic infection are higher among women than men. Hence, the evidence emphasizes 
screening women in this age group. 
Conclusion 
 As chlamydia and gonorrhea infection rates increase yearly among people less than 25 
years old (CDC, 2017b), it is important that primary care providers, including Advanced Practice 
Registered Nurses (APRN), are screening patients according to national clinical guidelines. 
CDC (2014c) and USPSTF (2014) both recommend screening sexually active women less than 
25 years old for chlamydia and gonorrhea annually. In 2017, NCQA (2019) HEDIS report 
revealed suboptimal chlamydia screening from participating payers. The clinical site for this EBP 
project noted lagging chlamydia and gonorrhea screening rates as well, thus supporting the 
need for intervention. 
 The EBP project sought to answer the following PICOT question: Among sexually active, 
nonpregnant women 15 to 24 years old (P), how does colleague education, routine sexual 
history taking, and subsequent collection of urine specimen for sexually active women (I) 
compared to no standard practice (C) improve chlamydia and gonorrhea screening uptake (O) 
over a 10-week period (T)? There was a nonsignificant increase in chlamydia and gonorrhea 
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screening uptake over the 10-week period. A longer time frame and larger sample size would 
further explore significance of the multifaceted intervention. Of the patients who were screened 
and eligible for testing, none declined. This information is encouraging and may indicate women 
are likely to get tested if their provider initiates the more difficult conversation related to sexual 
health. 
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ACRONYM LIST 
CDC: Centers for Disease Control and Prevention 
STD: Sexually transmitted disease 
CT: Chlamydia Trachomatis 
NG: Neisseria Gonorrhea 
CMA: Certified Medical Assistant 
USPSTF: United States Preventive Services Task Force 
STI: Sexually transmitted infection 
HIV: Human Immunodeficiency Virus 
HPV: Human Papilloma Virus 
PID: Pelvic inflammatory disease 
ISDH: Indiana State Department of Health 
NCQA: National Committee for Quality Assurance 
HEDIS: Healthcare Effectiveness Data and Information Set 
HMO: Health maintenance organization 
PPO: Preferred provider organization 
HHS: Department of Health and Human Services 
CMA: Certified Medical Assistant 
EMR: Electronic medical record 
EBP: Evidence-based practice 
DNP: Doctor of Nursing Practice 
JBI: Joanna Briggs Institute 
ED: Emergency Department 
RCT: Randomized controlled trial 
LC: Learning community 
IUD: Intrauterine device 
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FNP: Family Nurse Practitioner 
CPT: Current Procedural Terminology 
ICD: International Classification of Diseases 
CITI: Collaborative Institutional Training Initiative 
IRB: Institutional Review Board 
HIPAA: Health Insurance Portability and Accountability Act 
SPSS: Statistical Package for Social Sciences 
APRN: Advanced Practice Registered Nurses 
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